Ginès, Pere
Solà, Elsa
Angeli, Paolo
Wong, Florence
Nadim, Mitra K.
Kamath, Patrick S.
Article History
First Online: 13 September 2018
Change Date: 15 October 2018
Change Type: Correction
Change Details: The original version of this article omitted an initial from the name of contributing author Patrick S. Kamath, who was listed as Patrick Kamath. The article has now been corrected.
Competing interests
: P.G. declares that he is a member of advisory boards for Ferring Pharmaceuticals, Intercept Pharmaceuticals, Martin Pharmaceuticals and Novartis. He has received research funds from Grifols and Sequana Medical AG. P.A. declares that he is a member of the advisory board for Sequana Medical AG and that he has no financial disclosures. F.W. declares grant support from and consultancy for Mallinckrodt and consultancy for Conatus and Ferring Pharmaceuticals. E.S., M.K.N. and P.S.K. declare no competing interests.